A 55-year-old male with a history of diffuse large B cell lymphoma (DLBCL) presented with right-arm weakness, expressive dysphasia, and left Horner’s syndrome. CT brain demonstrated multiple left supratentorial masses, and involvement including the left midbrain (Fig. 1a). Disease recurrence was diagnosed following stereotactic biopsy. 18F-FDG PET/CT of the whole body 2 weeks post-biopsy for complete staging demonstrated the masses to be markedly FDG-avid, with the most FDG-avid focus within the left midbrain (Fig. 1b, SUVmax = 19.4). No active extracranial disease was demonstrated. There was a mild generalised reduction in metabolism throughout the left cerebral grey matter compared to the right, with reduced FDG uptake throughout the contralateral cerebellar hemisphere (Fig. 1c, d, coronal images) in keeping with crossed cerebellar diaschisis (CCD).
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.